
Presented by
Management Forum
Navigate global market access for medical device software with insights on international regulations, reimbursement strategies, and Health Technology Assessment (HTA) to improve your product’s chances of commercial success
This course will provide a clear understanding of different market access requirements for medical device software.
As demand surges for Digital Health (DH) solutions worldwide, understanding and navigating international regulations is paramount for market access success. This course will equip professionals with the knowledge to successfully enter into different international markets, improving the chances of commercial success by understanding country-specific requirements.
With an increased impact on clinical management, a higher bar for evidence is required for regulatory approval and adoption, but also an increased stakeholder willingness to pay for the service provided. Although at the moment, there’s no one-size-fits all approach, there is a global trend to increase DHT adoption through value-based pricing and reimbursement mechanisms. This growing trend has prompted countries, both within and outside the European Union (EU), to pilot various market authorization and access schemes, providing guidelines for coverage, and/or clear pathways for reimbursement of DHTs. This intensive course provides a comprehensive overview of the different national DHT market access and reimbursement strategies, presenting an overview of the current state of affairs.
The program will be highly interactive, using real-life examples and state-of-the-art practices across different global jurisdictions. Practical insights will be provide, hands-on exercises, and case studies to guide you through the intricate decisions needed that affect your market access processes.
The course will cover:
This course is part of our Regulatory Affairs Training course collection, which features updates on the latest regulations to registration procedures and strategies.
This course is for any professionals involved in market access for medical devices, including:
Catarina Carrão is the founder of BioSciPons, a life sciences research organisation specialising in health technologies clinical development, evaluation and assessment, with expertise in AI/ML-enabled technologies. She co-ordinates expert teams to bridge the gap between innovation and regulatory compliance, helping developers navigate complex requirements while meeting the expectations of Notified Bodies and the FDA.
Catarina's academic background includes a Marie-Curie Fellowship at Charité Berlin, and Postdoctoral Fellowship at Yale's University Cardiovascular Research Center. She is a Fellow of the American Heart Association (FAHA) since 2013, Delegate of the European Society of Cardiology (ESC), and Professional member of the Health Technology Assessment International (HTAi) organization. She is an expert for the European Commission HaDEA on clinical investigations and Digital Health Technologies, and for the European Innovation and Technology (EIT) Council Health Cluster.
She has presented at RAPS Euroconvergence, the ESC Digital & AI Summit, and DIA Europe on AI/ML medical device regulation, post-market monitoring, and reimbursement pathways. Her recent publications include book chapters and articles on machine learning best practices, AI trustworthiness, and EU MDR/IVDR clinical evaluation.
Switzerland
1 day
Typical duration
Pricing from:
We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.
Contact our in-house training experts Aleksandra Beer and Yesim Nurko to discuss your requirements:
Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to: